Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)
- Author
- TUBIANA, Roland1 ; CARCELAIN, Guislaine2 ; EL HABIB, Raphaelle8 ; COSTAGLIOLA, Dominique1 ; CALVEZ, Vincent3 ; AUTRAN, Brigitte2 ; KATLAMA, Christine1 ; VRAY, Muriel1 ; GOURLAIN, Karine3 ; DALBAN, Cécile1 ; CHERMAK, Aziza1 ; RABIAN, Claire4 ; VITTECOQ, Daniel5 ; SIMON, Anne6 ; BOUVET, Elisabeth7
[1] Département des Maladies Infectieuses et Tropicales, INSERM E0214, Hopital Pilié-Sulpêtriére, 47-83, Bid de l'Hôpital, 75651 Paris, France
[2] Laboratoire d'Immunologie Cellulaire et Tissulaire, INSERM U543 - Université Pierre et Marie Curie, Hôpital Pitié Salpêtrière, 47-83, Bld de l'Hôpital, 75651 Paris, France
[3] Laboratoire de Virologie, Hôpital Pitié-Salpêtrière, Paris, France
[4] Laboratoire d'Immunologie, Hôpital Saint-Louis, Paris, France
[5] Service Maladies Infectieuses, Hôpital Paul Brousse, Villejuif, France
[6] Service Médecine Interne, Hôpital Pilié-Salpêtrière, Paris, France
[7] Service des Maladies Infectieuses, Hôpital Bichat-Claude Bernard, Paris, France
[8] Aventis-Pasteur, Lyon, France
Vacciter Study group, France - Source
Vaccine. 2005, Vol 23, Num 34, pp 4292-4301, 10 p ; ref : 46 ref
- CODEN
- VACCDE
- ISSN
- 0264-410X
- Scientific domain
- Biotechnology; Immunology, immunopathology, allergology; Microbiology, infectious diseases; Virology
- Publisher
- Elsevier, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Clinical trial HIV-recombinant canarypox vaccine vCP1433 Therapeutic immunization
- Keyword (fr)
- Avipoxvirus Essai clinique Immunisation SIDA Vaccin Virus HIV1 Chordopoxvirinae Immunodéficit Immunopathologie Infection Lentivirus Poxviridae Retroviridae Virose Virus immunodéficience humaine Virus
- Keyword (en)
- Avipoxvirus Clinical trial Immunization AIDS Vaccine HIV-1 virus Chordopoxvirinae Immune deficiency Immunopathology Infection Lentivirus Poxviridae Retroviridae Viral disease Human immunodeficiency virus Virus
- Keyword (es)
- Avipoxvirus Ensayo clínico Inmunización SIDA Vacuna HIV-1 virus Chordopoxvirinae Inmunodeficiencia Inmunopatología Infección Lentivirus Poxviridae Retroviridae Virosis Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05F Applied microbiology / 002A05F04 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16952209
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.vaccine.2005.04.013 
https://dx.doi.org/10.1016/j.vaccine.2005.04.013
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2005.04.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"34\";s:8:\"\u0000*\u0000spage\";s:4:\"4292\";s:8:\"\u0000*\u0000epage\";s:4:\"4301\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TUBIANA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Roland\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"CARCELAIN, Guislaine\";i:1;s:19:\"EL HABIB, Raphaelle\";i:2;s:22:\"COSTAGLIOLA, Dominique\";i:3;s:15:\"CALVEZ, Vincent\";i:4;s:16:\"AUTRAN, Brigitte\";i:5;s:18:\"KATLAMA, Christine\";i:6;s:12:\"VRAY, Muriel\";i:7;s:16:\"GOURLAIN, Karine\";i:8;s:15:\"DALBAN, C\u00e9cile\";i:9;s:14:\"CHERMAK, Aziza\";i:10;s:14:\"RABIAN, Claire\";i:11;s:16:\"VITTECOQ, Daniel\";i:12;s:11:\"SIMON, Anne\";i:13;s:17:\"BOUVET, Elisabeth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2005.04.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"34\";s:8:\"\u0000*\u0000spage\";s:4:\"4292\";s:8:\"\u0000*\u0000epage\";s:4:\"4301\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TUBIANA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Roland\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"CARCELAIN, Guislaine\";i:1;s:19:\"EL HABIB, Raphaelle\";i:2;s:22:\"COSTAGLIOLA, Dominique\";i:3;s:15:\"CALVEZ, Vincent\";i:4;s:16:\"AUTRAN, Brigitte\";i:5;s:18:\"KATLAMA, Christine\";i:6;s:12:\"VRAY, Muriel\";i:7;s:16:\"GOURLAIN, Karine\";i:8;s:15:\"DALBAN, C\u00e9cile\";i:9;s:14:\"CHERMAK, Aziza\";i:10;s:14:\"RABIAN, Claire\";i:11;s:16:\"VITTECOQ, Daniel\";i:12;s:11:\"SIMON, Anne\";i:13;s:17:\"BOUVET, Elisabeth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2005.04.013\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2005.04.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"34\";s:8:\"\u0000*\u0000spage\";s:4:\"4292\";s:8:\"\u0000*\u0000epage\";s:4:\"4301\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TUBIANA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Roland\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"CARCELAIN, Guislaine\";i:1;s:19:\"EL HABIB, Raphaelle\";i:2;s:22:\"COSTAGLIOLA, Dominique\";i:3;s:15:\"CALVEZ, Vincent\";i:4;s:16:\"AUTRAN, Brigitte\";i:5;s:18:\"KATLAMA, Christine\";i:6;s:12:\"VRAY, Muriel\";i:7;s:16:\"GOURLAIN, Karine\";i:8;s:15:\"DALBAN, C\u00e9cile\";i:9;s:14:\"CHERMAK, Aziza\";i:10;s:14:\"RABIAN, Claire\";i:11;s:16:\"VITTECOQ, Daniel\";i:12;s:11:\"SIMON, Anne\";i:13;s:17:\"BOUVET, Elisabeth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2005.04.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"34\";s:8:\"\u0000*\u0000spage\";s:4:\"4292\";s:8:\"\u0000*\u0000epage\";s:4:\"4301\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TUBIANA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Roland\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"CARCELAIN, Guislaine\";i:1;s:19:\"EL HABIB, Raphaelle\";i:2;s:22:\"COSTAGLIOLA, Dominique\";i:3;s:15:\"CALVEZ, Vincent\";i:4;s:16:\"AUTRAN, Brigitte\";i:5;s:18:\"KATLAMA, Christine\";i:6;s:12:\"VRAY, Muriel\";i:7;s:16:\"GOURLAIN, Karine\";i:8;s:15:\"DALBAN, C\u00e9cile\";i:9;s:14:\"CHERMAK, Aziza\";i:10;s:14:\"RABIAN, Claire\";i:11;s:16:\"VITTECOQ, Daniel\";i:12;s:11:\"SIMON, Anne\";i:13;s:17:\"BOUVET, Elisabeth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2005.04.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"34\";s:8:\"\u0000*\u0000spage\";s:4:\"4292\";s:8:\"\u0000*\u0000epage\";s:4:\"4301\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TUBIANA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Roland\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"CARCELAIN, Guislaine\";i:1;s:19:\"EL HABIB, Raphaelle\";i:2;s:22:\"COSTAGLIOLA, Dominique\";i:3;s:15:\"CALVEZ, Vincent\";i:4;s:16:\"AUTRAN, Brigitte\";i:5;s:18:\"KATLAMA, Christine\";i:6;s:12:\"VRAY, Muriel\";i:7;s:16:\"GOURLAIN, Karine\";i:8;s:15:\"DALBAN, C\u00e9cile\";i:9;s:14:\"CHERMAK, Aziza\";i:10;s:14:\"RABIAN, Claire\";i:11;s:16:\"VITTECOQ, Daniel\";i:12;s:11:\"SIMON, Anne\";i:13;s:17:\"BOUVET, Elisabeth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
